Syed, I.B. and Nannapaneni, M. 2022. Related Substances Method Development and Validation of Axitinib, Zanubrutinib and Upadacitinib Using RP-HPLC and its Degradation Products were Characterized by Using LC-MS/MS. International Journal of Pharmaceutical Investigation. 13, 1 (Dec. 2022), 113-121. DOI:https://doi.org/10.5530/223097131696.